Suppr超能文献

他林洛尔与柳氮磺胺吡啶在人体胃肠道中的相互作用。

Interaction of talinolol and sulfasalazine in the human gastrointestinal tract.

作者信息

Terhaag B, Palm U, Sahre H, Richter K, Oertel R

机构信息

Department of Clinical Pharmacology, Medical Academy of Dresden, FRG.

出版信息

Eur J Clin Pharmacol. 1992;42(4):461-2. doi: 10.1007/BF00280137.

Abstract

The absorption of talinolol (TA) 50 mg was investigated without and together with the co-administration of sulfasalazine (SASP) 4 g in 11 healthy young volunteers, in order to clarify gastrointestinal transit of TA. Without SASP, the tmax of TA was 2.8 h, Cmax was 112 ng.ml-1 and the half life was 12 h; the AUCo-t was 958 ng.ml-1.h. In the case of concomitant administration of SASP, TA was found only in serum from 3 individuals, with a Cmax of 23 ng.ml-1 and a mean AUCo-t of 84 ng.ml-1.h. TA was not detectable in 5 subjects and it was at the limit of detection (2 ng.ml-1) in 3 subjects. Pharmacokinetic analysis was not possible in any of those individuals. The reason for the interaction appears to be the adsorption of TA by SASP. An interval of 2-3 h should elapse between giving SASP and other drugs.

摘要

为明确他林洛尔(TA)的胃肠道转运情况,在11名健康年轻志愿者中研究了50毫克TA在未联合和联合使用4克柳氮磺胺吡啶(SASP)时的吸收情况。未使用SASP时,TA的达峰时间(tmax)为2.8小时,最大血药浓度(Cmax)为112纳克/毫升,半衰期为12小时;药时曲线下面积(AUCo-t)为958纳克/毫升·小时。在联合使用SASP的情况下,仅在3名个体的血清中检测到TA,Cmax为23纳克/毫升,平均AUCo-t为84纳克/毫升·小时。5名受试者中未检测到TA,3名受试者中的TA处于检测限(2纳克/毫升)。这些个体均无法进行药代动力学分析。这种相互作用的原因似乎是SASP对TA的吸附作用。给予SASP和其他药物之间应间隔2至3小时。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验